Showing results (481-490 of 563) with videos related to

Sort By:
Pageof 57
Diabetes Care|April 30, 2002
Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetesBo Ahrén, Erik Simonsson, Hillevi Larsson, et al.
Oncogene|August 31, 2004
Silencing of androgen-regulated genes using a fusion of AR with the PLZF transcriptional repressorJoanna Pike, David Holmes, Tahereh Kamalati, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|January 8, 2025
Reevaluating Normal-Flow Low-Gradient Severe Aortic Stenosis: Clinical Phenotypes and Outcomes in Severe Aortic Stenosis Among Transcatheter Aortic Valve Replacement PatientsAmro Badr, Mustafa Suppah, Kamal Awad, et al.
JACC. Clinical Electrophysiology|November 7, 2025
Atrial Fibrillation Recurrence After Left Atrial Appendage Occlusion in Patients Undergoing Ablation: OPTION Trial Sub-analysisArwa Younis, Devi G Nair, Luigi Di Biase, et al.
Heart Rhythm O2|July 31, 2023
Design and rationale of the MODULAR ATP global clinical trial: A novel intercommunicative leadless pacing system and the subcutaneous implantable cardioverter-defibrillatorMichael S Lloyd, Amy J Brisben, Vivek Y Reddy, et al.
Heart Rhythm|November 7, 2016
Use of non-warfarin oral anticoagulants instead of warfarin during left atrial appendage closure with the Watchman deviceYoshinari Enomoto, Varuna K Gadiyaram, Carola Gianni, et al.
Stroke|February 27, 2023
Research Opportunities in Stroke Prevention for Atrial Fibrillation: A Report From a National Heart, Lung, and Blood Institute Virtual WorkshopAlan S Go, Sana M Al-Khatib, Patrice Desvigne-Nickens, et al.
Mayo Clinic Proceedings|August 2, 2024
Transcatheter Aortic Valve Replacement Outcomes During the Public Health Emergency Flexibility PeriodDaniel B Spoon, Sean Tunis, Jay Giri, et al.
Health Affairs (Project Hope)|February 4, 2015
Transcatheter valve therapy registry is a model for medical device innovation and surveillanceJohn D Carroll, Jeff Shuren, Tamara Syrek Jensen, et al.
Circulation. Cardiovascular Quality and Outcomes|February 10, 2011
Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trialMichael P Hudson, Paul W Armstrong, William W O'Neil, et al.
Pageof 57